Feasibility Study for Treating Trichotillomania With Wearable Device and App System

Learn more about:
Related Clinical Trial
Technology Assisted Treatment for Trichotillomania Leveraging Technological Advancements to Improve the Treatment of Trichotillomania Internet CBT for Trichotillomania and Skin Picking Disorder Developing Effective Response Inhibition Training for Symptom Relief in OCD and Trichotillomania Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals Evaluation of a Brief Surf the Urge Intervention Feasibility Study for Treating Trichotillomania With Wearable Device and App System Cognitive Behavioral Treatment of Pediatric Trichotillomania Telepsychotherapy for the Treatment of Adolescents With Trichotillomania Stepped Care in the Treatment of Trichotillomania Response Inhibition Training for Individuals With Trichotillomania Cognitive Behavioral Therapy for Trichotillomania Examining Behavior Therapy for Trichotillomania in Children and Adolescents Comprehensive Behavioral (ComB) Model of Treatment for Trichotillomania Methylphenidate in ADHD With Trichotillomania Marinol in Trichotillomania or Obsessive Compulsive Disorder Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors Cognitive Training in Patients With Trichotillomania (Hair-pulling Disorder) Olanzapine in the Treatment of Hair Pulling (Trichotillomania) A Study in Patients With Trichotillomania Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania Inositol in Trichotillomania Trial of Aripiprazole in Trichotillomania Habit Reversal Training for Children and Adolescents With Trichotillomania Naltrexone in the Treatment of Trichotillomania N-Acetylcysteine for Pediatric Trichotillomania Online Response Inhibition Training for Trichotillomania N-Acetyl Cysteine in Trichotillomania Trichotillomania: Group Cognitive-Behavioral Therapy Efficacy of COMB (Comprehensive Behavioral) Model of Treatment of Trichotillomania Milk Thistle in Trichotillomania in Children and Adults Cognitive Behavioral Group Therapy for Trichotillomania (Hair Pulling Disorder) Testing a New Therapy for Trichotillomania Online Treatment of Trichotillomania

Brief Title

Feasibility Study for Treating Trichotillomania With Wearable Device and App System

Official Title

Feasibility Study for Treating Trichotillomania With Wearable Device and App System Using Habit Reversal Training

Brief Summary

      Trichotillomania is characterized by recurrent hair pulling resulting in hair loss causing
      significant distress and impairment which persists despite repeated attempts to stop.
      Behavioral based therapies focused on increasing awareness of hair pulling followed by the
      use of an incompatible behavior have proven effective. In an effort to enhance awareness, a
      wrist worn motion detection device was created. In this study, we will test the feasibility
      of the HabitAware device and accompanying app as a system for delivering self-administered
      habit reversal training (HRT).

Study Type


Primary Outcome

Percentage of participants that wore the device for 6 hours per day and more than 4 days per week.

Secondary Outcome

 Percentage of participants that reported the device >3 on a scale of 1-5 for accuracy.




Device and app system designed for participant to self-administer Habit Reversal Training

Study Arms / Comparison Groups

 Experimental group - HabitAware condition
Description:  This group will receive the device which alerts the participant when performing hair pulling behavior and the app which provides psychoeducation and components of Habit Reversal Training.


* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status


Estimated Enrollment


Start Date

January 16, 2020

Completion Date

March 4, 2020

Primary Completion Date

March 4, 2020

Eligibility Criteria

        Inclusion Criteria:

          1. 18 years of age or older

          2. Speak fluent English

          3. Current diagnosis of TTM

          4. Score above the normative mean on the automatic pulling subscale of the MIST-A

          5. Not on psychotropic medication or on a stable dose (i.e., same dose for past 6 weeks)

        Exclusion Criteria:

          1. Currently receiving psychotherapy

          2. Other psychiatric condition requiring more immediate care

          3. Have previously used any behavior awareness devices (e.g. Keen)




18 Years - N/A

Accepts Healthy Volunteers



, , 

Location Countries

United States

Location Countries

United States

Administrative Informations



Organization ID


Secondary IDs


Responsible Party


Study Sponsor

HabitAware Inc.


 Marquette University

Study Sponsor

, , 

Verification Date

April 2020